Opioid Prescriptions Rising: Irish Study Reveals Trend
ireland’s Painkiller Prescriptions Soar as Access to Alternatives Lags Behind England
Ireland is experiencing a significant surge in prescriptions for pain medication, notably opioids and paracetamol, while England has seen a decline, according to new research. The study, published in the british Journal of Clinical Pharmacology, points to disparities in healthcare access and prescribing practices as key factors driving the trend.
researchers from the Royal College of Surgeons in Ireland (RCSI) examined national prescribing data from 2014-2022, comparing the Republic of Ireland’s General Medical Services (GMS) scheme – covering approximately one-third of the population with medical cards – to data from all general practices in England.
The analysis revealed a concerning 25 per cent increase in opioid use in Ireland over the eight-year period. Prescriptions for paracetamol rose even more dramatically, jumping by 50 per cent. Specific medications like codeine, tapentadol, and oxycodone also saw ample increases. In stark contrast, England largely experienced decreasing use across most pain medication classes during the same timeframe.
By 2022, Irish prescribing levels were substantially higher than in England: twice as high for opioids, four times higher for anti-inflammatories, and nearly five times higher for paracetamol.”Many of these medications carry risks such as dependency which can be worsened by overprescribing,” warned Prof Frank Moriarty, senior author of the study and associate professor at the RCSI school of pharmacy and bimolecular sciences.
While acknowledging demographic differences between the study populations – the NHS data covers the entire English population, while the Irish data focuses on GMS patients who tend to be older – researchers identified a critical gap in access to option treatments. England offers broader access to pain clinics and non-pharmacological interventions like physical therapy through the NHS. In Ireland, these services are less readily available, particularly for medical card holders who may not be able to afford private care.
Long waiting lists for surgery in Ireland are also believed to be contributing to the increased reliance on strong painkillers. “More decisions to prescribe [strong painkillers] for longer than or else” are likely being made while patients await surgical intervention, Prof Moriarty explained. Prolonged use increases a patient’s tolerance and potential for dependence.
The study stops short of definitively labeling prescriptions as “over-prescriptions,” acknowledging the complex assessment required between doctor and patient.”Ultimately it comes down to an assessment between the prescriber and the patient, and what is in the patient’s best interests. Sometimes the person is dealing with very severe pain and the prescription might potentially be the most appropriate course of action so the patient has a good quality of life,” Prof Moriarty stated.
However, the researchers emphasize the need for systemic changes to reverse the upward trend. Addressing lengthy surgical wait times and ensuring patients have “access to safe, evidence-based alternatives to medications” are crucial steps.
The research was a collaborative effort involving the HSE’s Quality and Patient Safety Directorate,University of Oxford,University College Cork,and University College Dublin. The findings raise importent questions about healthcare access, prescribing practices, and the need for a more holistic approach to pain management in Ireland.
